Amy Baxter
Staff ReporterAmy Baxter is a staff reporter for PharmaVoice. Before joining the team, she served as an editor and reporter in the B2B healthcare space for eight years at Health Exec and Home Health Care News. She also covered the retail industry as editor of Retail Leader, and hosted an Hermes award-winning weekly podcast and video interview series, Trend Talk, featuring industry executives and experts. A lifelong sailor, Amy has taken her media skills on the water to cover regattas and sailing events across the country. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Race to Mackinac Island. She is based in Florida.
107 articles by Amy Baxter
-
Is the FDA headed for a major reorganization?
April 30, 2025 -
FDA’s job cuts paint mixed picture for drugmakers’ R&D plans
April 28, 2025 -
Trump reveals pharma reform priorities in drug pricing executive order
April 23, 2025 -
Can anything threaten Novo and Lilly’s obesity market dominance?
April 21, 2025 -
Novartis scores NFL deal to tackle health outcomes
April 17, 2025 -
‘Chaos’ in the biotech market has dampened hopes of a rebound. What does that mean for dealmaking and IPOs?
April 15, 2025 -
US vs. EU: When it comes to novel Alzheimer’s drugs, regulators can’t seem to agree
April 7, 2025 -
Is the FDA ‘finished’? Leadership drain hits agency hard.
April 2, 2025 -
In the obesity triple-agonist blockbuster race, a familiar battle looms: Novo vs. Lilly
March 31, 2025 -
Rx-to-OTC rule gets pushed back — again
March 26, 2025 -
Lilly, Novo expand DTC reach of obesity meds after compound win
March 24, 2025 -
Vaccine makers face mRNA backlash as states seek further restrictions
March 19, 2025 -
Roche’s obesity deal with Zealand Pharma tees up rival for GLP-1s
March 17, 2025 -
IRA reforms, including a small molecule fix, could be on the table. Will Trump and the GOP make the leap?
March 12, 2025 -
The first new type of drug for Tourette syndrome in over 50 years is close to the FDA’s doorstep
March 11, 2025 -
How will Makary lead FDA amid workforce cuts and RFK Jr.s’ influence?
March 7, 2025 -
How pharma CEO pay shifted for these 4 companies last year
March 3, 2025 -
Kennedy’s MAHA agenda is tackling ‘conflicts of interest’ — and could take aim at FDA adcomms
Feb. 24, 2025 -
Challenges mount for vaccine makers
Feb. 19, 2025 -
The kids are alright: How pharma can make inroads with Gen Z
Feb. 12, 2025 -
Beyond GLP-1s? This biotech is exploring longer-term metabolic treatments
Feb. 10, 2025 -
RFK Jr. will face these critical tests if confirmed as head of the HHS
Feb. 5, 2025 -
Is federal funding frozen? Has it already thawed? Flip-flop leaves biopharma on edge
Jan. 31, 2025 -
A long-awaited alternative to opioids is on the FDA doorstep. Can Vertex seal the deal?
Jan. 29, 2025 -
An ALS treatment wave is approaching, and this biotech CEO is ready to surf
Jan. 27, 2025